Combination Immunotherapy and Immune Response Assessment of Brain Tumours

5,493
Total downloads
16k
Total views and downloads

Articles

CASE REPORT

Published on 14 Nov 2024

Case report: Intravascular large B cell lymphoma mimicking acute demyelinating encephalomyelitis after SARS-CoV-2 reinfection: diagnostic value of advanced MRI techniques and the literature review with the assistance of ChatGPT

Sujuan Chen
Mingchen Cai
Guirong Tan
Ruomi Guo
Qiong Liang
Hainan Li
Xiang Liu

doi 10.3389/fimmu.2024.1478163

696 views

CASE REPORT

Published on 14 Oct 2024

Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report

Juan Ni
Xiaoyue Dong
Huafeng Shou
Qing Xu
Zhuomin Yin
Hanmei Lou

doi 10.3389/fimmu.2024.1434697

605 views

ORIGINAL RESEARCH

Published on 11 Sep 2024

Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study

Xiaodong Niu
Tao Chang
Yuekang Zhang
Yanhui Liu
Yuan Yang
Qing Mao

doi 10.3389/fimmu.2024.1447879

629 views

CASE REPORT

Published on 10 May 2024

Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC

Weijia Wu
Jinyou Guo
Lianxiang He
Qi Deng
Xianping Huang

doi 10.3389/fonc.2024.1390343

599 views

CASE REPORT

Published on 04 Apr 2024

Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas

Jiapeng Liu
Shuli Hu
Haihui Jiang
Yong Cui

doi 10.3389/fimmu.2024.1369972

1,011 views
1 citation

ORIGINAL RESEARCH

Published on 26 Feb 2024

Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy

Xue Yang
Zehao Cai
Ce Wang
Chenggang Jiang
Jianguang Li
Feng Chen
Wenbin Li

doi 10.3389/fimmu.2024.1362543

2,221 views
1 citation

ORIGINAL RESEARCH

Published on 05 Jan 2024

IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy

Feng Ye
Lichong Wang
Yuanyou Li
Chengyuan Dong
Liangxue Zhou
Jianguo Xu

doi 10.3389/fimmu.2023.1338244

3,545 views
3 citations

REVIEW

Published on 20 Oct 2023

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma

Bryan Gardam
Tessa Gargett
Michael P. Brown
Lisa M. Ebert

doi 10.3389/fimmu.2023.1261257

3,024 views
7 citations

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

16kTopic views
10kArticle views
5,493Article downloads

View impact

Submit your idea

Articles

Case report: Intravascular large B cell lymphoma mimicking acute demyelinating encephalomyelitis after SARS-CoV-2 reinfection: diagnostic value of advanced MRI techniques and the literature review with the assistance of ChatGPT

Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report

Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study

Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC

Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas

Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy

IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma

Frontiers in Immunology

Participating Journals

Impact